JONATHAN G DRACHMAN Insider Trading $NLTX Neoleukin Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN G DRACHMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN G DRACHMAN. JONATHAN G DRACHMAN is CMO & EVP, R & D in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in Neoleukin Therapeutics, Inc. ($AQXP) and See Remarks in Neoleukin Therapeutics, Inc. ($AQXP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Harpoon Therapeutics, Inc. ($HARP).
JONATHAN G DRACHMAN in Neoleukin Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JONATHAN G DRACHMAN: See Remarks, President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 12 2020
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JONATHAN G DRACHMAN in Neoleukin Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CALA, HARP, NLTX, SGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12 2020 | NLTX | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Option Exercise | A | 12.00 | 420,000 | 5,040,000 | 420,000 | |
| Dec 20 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Buy | P | 8.40 | 119,047 | 999,995 | 2,198,686 | 2.1 M to 2.2 M (+5.72 %) |
| Dec 20 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Buy | C | 0.00 | 1,261,600 | 0 | 2,079,639 | 818 K to 2.1 M (+154.22 %) |
| Dec 20 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Sell | C | 0.00 | 12,616 | 0 | 0 | 12.6 K to 0 (-100.00 %) |
| Sep 11 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Buy | P | 3.30 | 136,436 | 449,898 | 584,428 | 448 K to 584.4 K (+30.46 %) |
| Sep 11 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Buy | P | 3.08 | 36,742 | 113,290 | 447,992 | 411.3 K to 448 K (+8.93 %) |
| Sep 11 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Buy | P | 2.85 | 76,822 | 218,559 | 411,250 | 334.4 K to 411.3 K (+22.97 %) |
| Sep 04 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Option Exercise | A | 2.80 | 1,650,000 | 4,620,000 | 1,650,000 | |
| Aug 12 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Grant | A | 0.00 | 7,428 | 0 | 7,428 | 0 to 7.4 K |
| Aug 12 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Grant | A | 0.00 | 334,428 | 0 | 334,428 | 0 to 334.4 K |
Page: 1